サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1405819

酵素創傷デブリードメントの市場規模、シェア、動向分析レポート：タイプ別、製品別、最終用途別、地域別、セグメント別予測、2023年～2030年

Enzymatic Wound Debridement Market Size, Share & Trends Analysis Report By Type, By Product, By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 79 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
酵素創傷デブリードメントの市場規模、シェア、動向分析レポート：タイプ別、製品別、最終用途別、地域別、セグメント別予測、2023年～2030年
出版日: 2023年12月07日
発行: Grand View Research
ページ情報: 英文 79 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

酵素創傷デブリードメント市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の酵素創傷デブリードメント市場規模は2030年までに13億9,180万米ドルに達すると予測され、予測期間中のCAGRは6.2%です。

技術的に高度な製品のイントロダクションや慢性疾患の罹患率の上昇が、成長を助長する主な要因のいくつかです。

世界の酵素創傷デブリードメント製品に対する需要の高まりにより、研究者や主要企業が様々な取り組みを行い、技術的に先進的な製品を開発しており、市場成長を後押しすると予想されます。これまで、コラゲナーゼベースの酵素創傷除去製品は慢性・急性創傷の治療に、パパインベースの製品は慢性創傷の治療に主に使用されてきました。このような製品の使用に対する認識が高まっているため、技術的に進歩した製品がいくつか市場に投入されています。例えば、以前はデブライディング・ゲル・ドレッシング（DGD）と呼ばれていたネクソブリッド（NXB）は、パイナップルのブロメライン酵素群に由来するもので、2017年に発売されました。NXBは、深い熱傷創の治療に効果的に使用できる酵素創傷デブリードメント剤です。

この製品は最近承認を取得し、市場プレーヤーはこの製品を創傷ケア製品ポートフォリオとして発売するための取り組みを行っています。例えば、2019年5月、Vericel Corporationは北米での製品化を目指してMediWound Ltd.と供給契約および独占ライセンスを締結しました。また、同製品は欧州連合、米国、その他の国際市場でも承認を取得しています。従って、このような取り組みは予測期間中の成長にプラスの影響を与えると予想されます。

酵素創傷デブリードメント市場レポート・ハイライト

  • 売上高では、外傷症例の増加により、急性創傷分野が2022年に最大のシェアを占めました。
  • 慢性創傷を患う老年人口が増加し、入院よりも在宅ケアを好むことから、在宅ケア分野は予測期間中に最も速い成長率を示すと予想されます。
  • コラゲナーゼ製品セグメントは、慢性創傷の増加により2022年に最大のシェアを占めました。
  • アジア太平洋地域は糖尿病患者の増加により、予測期間中に最も速い成長が見込まれます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 業界の展望

  • 市場セグメンテーション
  • 市場変数分析
  • 普及と成長の見通しマッピング
  • ビジネス環境分析ツール

第4章 酵素創傷デブリードメント市場：タイプの推定・動向分析

  • 酵素創傷デブリードメント市場：重要なポイント
  • 酵素創傷デブリードメント市場：タイプの変動と市場シェア分析、2022年および2030年
  • 慢性創傷
  • 急性創傷

第5章 酵素創傷デブリードメント市場：製品の推定・動向分析

  • 酵素創傷デブリードメント市場：重要なポイント
  • 酵素創傷デブリードメント市場：製品の変動と市場シェア分析、2022年および2030年
  • コラゲナーゼ製品
  • パパイン製品
  • その他

第6章 酵素創傷デブリードメント市場：最終用途の推定・動向分析

  • 酵素創傷デブリードメント市場：重要なポイント
  • 酵素創傷デブリードメント市場：最終用途の動向と市場シェア分析、2022年および2030年
  • 病院
  • ホームケア
  • その他

第7章 酵素創傷デブリードメント市場：地域の推定・動向分析

  • 地域別の見通し
  • 酵素創傷デブリードメント市場、地域別：重要なポイント
  • 北米
    • 市場推計・予測、2018～2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 会社/競合の分類
    • Convatec Inc.
    • Smith & Nephew
    • Molnlycke Health Care AB
    • Integra LifeSciences
    • SOLASCURE Limited
    • B. Braun
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
  • Table 3 North America enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America enzymatic wound debridement market, by end use, (USD Million) 2018 -2030
  • Table 5 North America enzymatic wound debridement market, by country, 2018 - 2030 (USD Million)
  • Table 6 U.S. enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
  • Table 7 U.S. enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
  • Table 8 U.S. enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
  • Table 10 Canada enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
  • Table 11 Canada enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Europe enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
  • Table 13 Europe enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
  • Table 14 Europe enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe enzymatic wound debridement market, by country, 2018 - 2030 (USD Million)
  • Table 16 Germany enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
  • Table 17 Germany enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
  • Table 18 Germany enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
  • Table 19 UK enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
  • Table 20 UK enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
  • Table 21 UK enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
  • Table 22 France enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
  • Table 23 France enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
  • Table 24 France enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Italy enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
  • Table 26 Italy enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
  • Table 27 Italy enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Spain enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
  • Table 29 Spain enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
  • Table 30 Spain enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Sweden enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
  • Table 32 Sweden enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
  • Table 33 Sweden enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Norway enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
  • Table 35 Norway enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
  • Table 36 Norway enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Denmark enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
  • Table 38 Denmark enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
  • Table 39 Denmark enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific enzymatic wound debridement market, by country, 2018 - 2030 (USD Million)
  • Table 44 China enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
  • Table 45 China enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
  • Table 46 China enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Japan enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
  • Table 48 Japan enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
  • Table 49 Japan enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
  • Table 50 India enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
  • Table 51 India enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
  • Table 52 India enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Australia enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
  • Table 54 Australia enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
  • Table 55 Australia enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Thailand enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
  • Table 57 Thailand enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
  • Table 58 Thailand enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
  • Table 59 South Korea enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
  • Table 60 South Korea enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
  • Table 61 South Korea enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Latin America enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
  • Table 63 Latin America enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
  • Table 64 Latin America enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Latin America enzymatic wound debridement market, by country, 2018 - 2030 (USD Million)
  • Table 66 Brazil enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
  • Table 67 Brazil enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
  • Table 68 Brazil enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Mexico enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
  • Table 70 Mexico enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
  • Table 71 Mexico enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
  • Table 72 Argentina enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
  • Table 73 Argentina enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
  • Table 74 Argentina enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa enzymatic wound debridement market, by type, (USD Million) 2018-2030
  • Table 76 Middle East and Africa enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa enzymatic wound debridement market, by country, 2018 - 2030 (USD Million)
  • Table 79 South Africa enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
  • Table 80 South Africa enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
  • Table 81 South Africa enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
  • Table 85 UAE enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
  • Table 86 UAE enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
  • Table 87 UAE enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
  • Table 89 Kuwait enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
  • Table 90 Kuwait enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market summary
  • Fig. 9 Enzymatic wound debridement market segmentation
  • Fig. 10 Market driver relevance analysis (Current & future impact)
  • Fig. 11 Market restraint relevance analysis (Current & future impact)
  • Fig. 12 Penetration & growth prospect mapping
  • Fig. 13 SWOT analysis, by a factor (political & legal, economic and technological)
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 Enzymatic wound debridement market product outlook: Key takeaways
  • Fig. 16 Enzymatic wound debridement market: Product movement analysis
  • Fig. 17 Collagenase product market, 2018 - 2030 (USD Million)
  • Fig. 18 Papain product market, 2018 - 2030 (USD Million)
  • Fig. 19 Other enzymatic wound debridement product market, 2018 - 2030 (USD Million)
  • Fig. 20 Enzymatic wound debridement market type outlook: Key takeaways
  • Fig. 21 Enzymatic wound debridement market: Type movement analysis
  • Fig. 22 Chronic wounds market, 2018 - 2030 (USD Million)
  • Fig. 23 Diabetic foot ulcers market, 2018 - 2030 (USD Million)
  • Fig. 24 Pressure ulcers market, 2018 - 2030 (USD Million)
  • Fig. 25 Venous leg ulcers market, 2018 - 2030 (USD Million)
  • Fig. 26 Acute wounds market, 2018 - 2030 (USD Million)
  • Fig. 27 Burn wounds market, 2018 - 2030 (USD Million)
  • Fig. 28 Other acute wounds market, 2018 - 2030 (USD Million)
  • Fig. 29 Enzymatic wound debridement market end-use outlook: Key takeaways
  • Fig. 30 Enzymatic wound debridement market: End-use movement analysis
  • Fig. 31 Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 32 Homecare market, 2018 - 2030 (USD Million)
  • Fig. 33 Others market, 2018 - 2030 (USD Million)
  • Fig. 34 North America market estimates and forecasts, 2018 - 2030
  • Fig. 35 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 36 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 37 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 38 UK market estimates and forecasts, 2018 - 2030
  • Fig. 39 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 40 France market estimates and forecasts, 2018 - 2030
  • Fig. 41 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 42 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 43 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 44 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 45 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 46 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 47 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 48 China market estimates and forecasts, 2018 - 2030
  • Fig. 49 India market estimates and forecasts, 2018 - 2030
  • Fig. 50 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 51 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 52 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 53 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 54 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 55 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 56 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 57 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 58 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 59 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 60 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 61 Kuwait market estimates and forecasts, 2018 - 2030
目次
Product Code: GVR-3-68038-259-4

Enzymatic Wound Debridement Market Growth & Trends:

The global enzymatic wound debridement market size is expected to reach USD 1,391.8 million by 2030, according to a new report by Grand View Research, Inc., exhibiting a 6.2% CAGR during the forecast period. Introduction of technologically advanced products and rise in incidence of chronic diseases are some of the key factors aiding growth.

Various initiatives are being undertaken by researchers and key players are developing technologically advanced products owing to rising demand for enzymatic wound debridement products globally, which is anticipated to boost market growth. Until now, collagenase-based enzymatic wound debridement products have been majorly used for treatment of chronic & acute wounds and papain-based products have been predominantly used for treatment of chronic wounds. Since awareness about the use of such products is increasing, several technologically advanced products are being introduced in the market. For instance, NexoBrid (NXB), previously referred to as Debriding Gel Dressing (DGD)-which is derived from pineapple Bromelain group of enzymes-was introduced in 2017. NXB is an enzymatic wound debriding drug that can be effectively used in treating deep burn wounds.

The product recently received approval and market players are undertaking initiatives to launch this product under their wound care product portfolio. For instance, in May 2019, Vericel Corporation entered into a supply agreement and exclusive license with MediWound Ltd. with an aim to commercialize the product in North America. The product also received approval in European Union, the U.S., and other international markets. Therefore, such initiatives are anticipated to positively impact growth over the forecast period.

Enzymatic Wound Debridement Market Report Highlights:

  • In terms of revenue, acute wounds segment held the largest share in 2022 owing to rising trauma cases
  • Homecare segment is expected to witness fastest growth rate over the forecast period owing to increasing geriatric population suffering from chronic wounds, who prefer homecare over hospital stay
  • Collagenase product segment held the largest share in 2022 due to rising incidence of chronic wounds
  • Asia Pacific is expected to witness fastest growth over the forecast period owing to rising number diabetic patients in this region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Product
    • 1.1.3. End Use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Product outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Industry Outlook

  • 3.1. Market Segmentation
  • 3.2. Market Variable Analysis
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
      • 3.2.2.1 Stringent regulatory policies
  • 3.3. Penetration & Growth Prospect Mapping
  • 3.4. Business Environment Analysis tools
    • 3.4.1. SWOT Analysis, by PEST
    • 3.4.2. Porter's five forces analysis

Chapter 4. Enzymatic Wound Debridement Market: Type Estimates & Trend Analysis

  • 4.1. Enzymatic Wound Debridement Market: Key Takeaways
  • 4.2. Enzymatic Wound Debridement Market: Type Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Chronic wounds
    • 4.3.1. Chronic wounds market estimates and forecast 2022 to 2030 (USD Million)
      • 4.3.1.1. Diabetic Foot Ulcers
      • 4.3.1.1.1. Diabetic foot ulcers market estimates and forecast 2022 to 2030 (USD Million)
      • 4.3.1.2. Pressure Ulcers
      • 4.3.1.2.1. Pressure ulcers market estimates and forecast 2022 to 2030 (USD Million)
      • 4.3.1.3. Venous Leg Ulcers
      • 4.3.1.3.1. Venous leg ulcers market estimates and forecast 2022 to 2030 (USD Million)
  • 4.4. Acute Wounds
    • 4.4.1. Acute wounds market estimates and forecast 2022 to 2030 (USD Million)
      • 4.4.1.1. Burns
      • 4.4.1.1.1. Burns market estimates and forecast 2022 to 2030 (USD Million)
      • 4.4.1.2. Other Acute Wounds
      • 4.4.1.2.1. Other acute wounds market estimates and forecast 2022 to 2030 (USD Million)

Chapter 5. Enzymatic Wound Debridement Market: Product Estimates & Trend Analysis

  • 5.1. Enzymatic Wound Debridement Market: Key Takeaways
  • 5.2. Enzymatic Wound Debridement Market: Product Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Collagenase Product
    • 5.3.1. Collagenase Product market estimates and forecasts, 2022 to 2030 (USD Million)
  • 5.4. Papain Product
    • 5.4.1. Papain Product market estimates and forecasts, 2022 to 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others market estimates and forecasts, 2022 to 2030 (USD Million)

Chapter 6. Enzymatic Wound Debridement Market: End-use Estimates & Trend Analysis

  • 6.1. Enzymatic Wound Debridement Market: Key Takeaways
  • 6.2. Enzymatic Wound Debridement Market: End-use Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Hospitals
    • 6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Homecare
    • 6.4.1. Homecare market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Enzymatic Wound Debridement Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Enzymatic Wound Debridement Market, by Region: Key Takeaways
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Sweden
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Norway
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. Saudi Arabia
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Convatec Inc.
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Smith & Nephew
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Molnlycke Health Care AB
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Integra LifeSciences
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. SOLASCURE Limited
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. B. Braun
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives